Gastroenterology Research and Practice / 2020 / Article / Tab 4 / Review Article
A Methodological and Reporting Quality Assessment of Systematic Reviews/Meta-Analyses about Chinese Medical Treatment for Gastroesophageal Reflux Disease Table 4 The result of PRISMA assessments.
Study Title Structured summary Rationale Objectives Protocol and registration Eligibility criteria Information sources Search Study selection Data collection process Data items Risk of bias in individual studies Summary measures Synthesis of results Risk of bias across studies Additional analyses Study selection Study characteristics Risk of bias within studies Results of individual studies Synthesis of results Risk of bias across studies Additional analysis Summary of evidence Limitations Conclusions Funding Scores Song [15 ] 1 0.5 1 0.5 0 0.5 0.5 1 0 1 0.5 1 1 1 1 0 1 1 0 1 1 1 1 0.5 1 1 0 19 Yang [16 ] 1 0.5 1 0.5 0 1 0.5 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 22.5 Zhao [17 ] 1 0.5 1 0.5 0.5 0.5 0.5 0.5 0 0 0 1 1 0.5 1 1 0.5 0.5 0.5 1 1 1 1 0 1 1 0 17 Chen [18 ] 1 0.5 1 0.5 0 0.5 1 0.5 1 0.5 1 0.5 1 1 0 0 1 0 1 1 1 0 1 1 0 1 0 17 Sun [19 ] 1 0.5 1 0.5 0 0.5 0.5 1 0 1 0 1 1 1 1 0.5 1 1 0 1 1 1 1 0 1 1 0 18.5 Zhang [20 ] 1 0.5 1 1 1 1 1 1 0 1 1 0 1 1 1 0 1 1 0.5 1 1 1 0 1 1 1 1 22 Wang [21 ] 1 0.5 1 0.5 0 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 23 Li [22 ] 1 0.5 1 0.5 0 0.5 0.5 1 0 1 0 1 1 1 1 0 1 1 0 1 1 1 0.5 0.5 1 1 0 18 Pei [23 ] 1 0.5 1 0.5 0 1 1 0.5 0.5 0 0 1 1 1 1 0 1 0 0.5 0 1 1 1 1 0.5 1 1 18 Guo [24 ] 1 0.5 1 0.5 0 1 1 0.5 0.5 0.5 0 1 1 1 1 1 0.5 1 1 1 1 1 1 1 1 1 0 21 Ling [25 ] 1 0.5 1 0.5 0.5 1 0.5 1 0 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 23 Zheng [26 ] 1 0.5 1 0.5 0 1 1 1 0 1 0 1 1 1 1 0 1 1 1 1 1 1 0 1 1 1 0 20 Zheng [27 ] 1 0.5 1 0.5 0 0.5 0.5 0 0 0 0 1 1 0.5 1 1 0.5 1 1 1 1 1 1 0 1 1 0 17 Ge [28 ] 1 1 1 1 0.5 0.5 0 1 1 0.5 1 0 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 20.5 Zhu [29 ] 1 0.5 1 1 0.5 0.5 0.5 1 1 1 1 0.5 1 1 1 0 1 1 0 1 1 1 0 1 1 1 1 21.5 Ghung [30 ] 1 0.5 0.5 1 0 1 0.5 1 0.5 1 1 0.5 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 22.5 Chen [31 ] 1 0.5 1 0.5 0.5 1 1 0.5 0.5 0.5 1 1 1 1 0 1 1 1 0.5 1 1 1 1 1 1 0.5 0 21 Chen [32 ] 1 0.5 1 0.5 0 0 0.5 1 0 1 0 1 1 1 1 0 1 1 0 1 1 1 1 0.5 1 1 0 18 Dai [33 ] 1 0.5 1 0.5 1 1 1 1 0.5 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 24.5 Li [34 ] 1 0.5 1 0.5 0 0 1 1 0 1 1 0.5 1 1 0.5 0 0.5 1 0.5 1 1 0 0.5 1 1 1 1 18.5 Xie [35 ] 1 0.5 1 0.5 0 1 1 1 0 0.5 1 1 1 1 0 0 0.5 1 1 0.5 1 0 1 0.5 0.5 0 1 17.5 Xiao [36 ] 1 0.5 1 0.5 0.5 1 0.5 1 0.5 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 1 23.5 Zhu [37 ] 1 0.5 1 0.5 1 1 1 1 0.5 1 1 1 1 1 1 1 0.5 1 1 1 1 0.5 0.5 1 1 1 1 24 Li [38 ] 1 0.5 1 0.5 0 1 1 1 0 0.5 1 0 1 0 0.5 0 1 0 1 1 1 1 0 0 0.5 0.5 1 16 Xie [39 ] 1 0.5 1 0.5 0 1 1 0.5 0 0.5 1 1 1 1 0.5 1 1 1 1 0 1 0 1 1 1 1 1 20.5 Fu [40 ] 1 0.5 1 1 0 1 1 1 0 1 1 0.5 1 1 1 0 0.5 1 0 1 1 1 0 1 1 1 1 20.5 Li [41 ] 1 0.5 1 0.5 0 1 1 1 0 0.5 1 0 1 0 0 0 1 0 1 1 1 1 0 0 0.5 0.5 1 15.5 Song [42 ] 1 0.5 1 0.5 0 0.5 0.5 1 0 1 0 1 1 1 1 0 1 1 0 1 1 1 1 0.5 1 1 0 18.5 Wu [43 ] 1 0.5 1 0.5 0 0.5 1 1 0 1 1 0 1 1 1 0 0.5 1 0 1 1 1 0 1 1 1 1 19 Xiao [44 ] 1 0.5 1 0.5 0 1 1 0.5 0.5 0.5 0 1 1 1 1 0 1 0 0.5 0 1 1 1 1 0.5 1 1 18.5 Song [44 ] 1 0.5 1 0.5 0 1 1 0.5 0.5 0.5 0 1 1 1 1 1 1 1 0 1 1 1 1 1 1 0.5 1 21 Li [45 ] 1 0.5 1 0.5 0 1 1 1 0.5 0 1 0 1 0 0 0 1 0 0.5 1 1 1 0 0 0.5 0.5 1 15 Li [46 ] 1 0.5 1 0.5 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 25 Yes (%) 33 (100%) 0 (0%) 33 (100%) 5 (15.2%) 0 (0%) 22 (66.6%) 20 (60.6) 24 (72.8%) 4 (13.3%) 19 (57.6%) 22 (66.7%) 22 (66.7%) 33 (100%) 28 (8.8%) 25 (75.7%) 23 (69.7%) 25 (75.7%) 26 (78.8%) 16 (48.7%) 29 (87.9%) 33 (100%) 29 (87.9%) 21 (63.6%) 22 (66.6%) 26 (78.8%) 27 (81.8%) 20 (60.6%) Partial yes (%) 0 (0%) 33 (100%) 0 (0%) 14 (84.8%) 0 (0%) 9 (27.3%) 12 (36.4%) 8 (24.2%) 10 (30.1%) 10 (30.1%) 0 (0%) 5 (15.2%) 0 (0%) 2 (6.1%) 3 (9.1%) 1 (3.0%) 8 (24.2%) 1 (3.0%) 7 (21.2%) 1 (3.0%) 0 (0%) 1 (3.0%) 3 (9.1%) 5 (15.2%) 6 (18.2%) 5 (15.2%) 0 (0%) No (%) 0 (0%) 0 (0%) 0 (0%) 0 (0%) 33 (100%) 2 (6.1%) 1 (3.0%) 1 (3.0%) 19 (57.6%) 4 (13.3%) 11 (33.3%) 6 (18.2%) 0 (0%) 3 (9.1%) 5 (15.2%) 9 (27.3%) 0 (0%) 6 (18.2%) 10 (30.1%) 3 (9.1%) 0 (0%) 3 (9.1%) 9 (27.3%) 6 (18.2%) 1 (3.0%) 1 (3.0%) 13 (39.4%)